Marc Andelman wrote:
>> mark wrote:
>> No one benefits.
Wrong, as stated in the editorial 200,000 jobs are one measure of the
benifit. also,patients benifit (in the health science field anyway) where do
you think the endostatin and angiostatin were first discovered? and where do
you think entreMed arose from?
> That is all I have been saying if anyone is listening.
but marc most of those companies are, at least from her arguement, the result
of patents and licensing after the bayh/dole act.